METAGENOMI THERAPEUTICS INC MGX
ASignal's systematic analysis rates MGX as Bearish.
Reflects the latest available analysis · analyzed Nov 5, 2026
The case on MGX
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Current ratio of 4.50x indicates strong short-term liquidity
- Quick ratio of 4.40x suggests ability to cover short-term obligations without inventory
- Debt-to-equity ratio of 0.34x is below 0.5, indicating low leverage
- Price near Bollinger Lower Band (0.68) suggests potential mean reversion
- Negative MACD and price momentum indicate ongoing downtrend
- Forward P/E of -0.43x and negative EV/EBITDA suggest unprofitability
- Negative return on equity (-60.61%) and return on assets (-28.19%) reflect poor capital efficiency
- Operating cash flow and free cash flow are deeply negative
- Extremely high operating margin (11195.72%) is a data anomaly or non-recurring item
- Only one news source (Yahoo) and no Reddit mentions indicate low market interest
See the full verdict on MGX
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes MGX
Most investors never get a second opinion, let alone several. ASignal runs MGX past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.